Clinical Trials · NCT07481630
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 400
- Start date
- Apr 2026
- Locations
- 82 sites, 10 countries
- Primary endpoint
- Relative change in body weight